Head and neck cancer: improving outcomes with a multidisciplinary approach

References

• National Comprehensive Cancer Network: Clinical Practice Guidelines in OncologyHead and Neck Cancer v12017 Available from: https://www.nccn.org/professionals/physician_gls/f_guidelines.asp#site
   Google Scholar
• WeinbergerPMYuZHafftyBGMolecular classification identifies a subset of human papillomavirus–associated oropharyngeal cancers with favorable prognosisJ Clin Oncol200624573674716401683
   PubMed Web of Science ®Google Scholar
• BaxiSFuryMGanlyIRaoSPfisterDGTen years of progress in head and neck cancersJ Natl Compr Canc Netw201210780681022773796
   PubMed Web of Science ®Google Scholar
• MaxwellJHGrandisJRFerrisRHPV-associated head and neck cancer: unique features of epidemiology and clinical managementAnnu Rev Med2016679110126332002
   PubMed Web of Science ®Google Scholar
• AdelsteinDJLiYAdamsGLAn intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancerJ Clin Oncol2003211929812506176
   PubMed Web of Science ®Google Scholar
• ForastiereAAZhangQWeberRSLong-term results of RTOG 91–11: a comparison of three nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancerJ Clin Oncol201331784585223182993
   PubMed Web of Science ®Google Scholar
• BonnerJAHarariPMGiraltJRadiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survivalLancet Oncol2010111212819897418
   PubMed Web of Science ®Google Scholar
• CocksHAh-SeeKCapelMTaylorPPalliative and supportive care in head and neck cancer: United Kingdom National Multidisciplinary GuidelinesJ Laryngol Otol2016130S2S198S20727841131
   PubMed Web of Science ®Google Scholar
• BossiPAlfieriSInvestigational drugs for head and neck cancerExpert Opin Investig Drugs2016257797810
   PubMed Web of Science ®Google Scholar
• BadoualCHansSMerillonNPD-1-expressing tumor-infiltrating T cells area favorable prognostic biomarker in HPV-associated head and neck cancerCancer Res201373112813823135914
   PubMed Web of Science ®Google Scholar
• HolsingerFCFerrisRLTransoral endoscopic head and neck surgery and its role within the multidisciplinary treatment paradigm of oropharynx cancer: robotics, lasers, and clinical trialsJ Clin Oncol201533293285329226351337
   PubMed Web of Science ®Google Scholar
• SchindlerADenaroNRussiEGDysphagia in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensusAm J Otolaryngol2013341576023218113
   PubMed Web of Science ®Google Scholar
• MirabileAAiroldiMRipamontiCPain management in head and neck cancer patients undergoing chemo-radiotherapy: Clinical practical recommendationsCrit Rev Oncol Hematol20169910010626712589
   PubMed Web of Science ®Google Scholar
• De SanctisVBossiPSanguinetiGMucositis in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus statementsCrit Rev Oncol Hematol201610014716626947812
   PubMed Web of Science ®Google Scholar
• BuglioneMCavagniniRDi RosarioFOral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Xerostomia and trismus (Part 2). Literature review and consensus statementCrit Rev Oncol Hematol2016102475427061883
   PubMed Web of Science ®Google Scholar
• PillayBWoottenACCroweHThe impact of multidisciplinary team meetings on patient assessment, management and outcomes in oncology settings: a systematic review of the literatureCancer Treat Rev201642567226643552
   PubMed Web of Science ®Google Scholar
• KellySLJacksonJEHickeyBESzallasiFGBondCAMultidisciplinary clinic care improves adherence to best practice in head and neck cancerAm J Otolaryngol2013341576023218113
   PubMed Web of Science ®Google Scholar
• BergaminiCLocatiLBossiPDoes a multidisciplinary team approach in a tertiary referral centre impact on the initial management of head and neck cancer?Oral Oncol201654545726774920
   PubMed Web of Science ®Google Scholar
• BirchallMBaileyDKingPSouth West Cancer Intelligence Service Head and Neck Tumor PanelEffect of process standards on survival of patients with head and neck cancer in the south and west of EnglandBr J Cancer20049181477148115467772
   PubMed Web of Science ®Google Scholar
• FriedlandPLBozicBDewarJKuanRMeyerCPhillipsMImpact of multidisciplinary team management in head and neck cancer patientsBr J Cancer201110481246124821448166
   PubMed Web of Science ®Google Scholar
• WangYHKungPTTsaiWCTaiCJLiuSATsaiMHEffects of multidisciplinary care on the survival of patients with oral cavity cancer in TaiwanOral Oncol201248980381022534006
   PubMed Web of Science ®Google Scholar
• PatilRDMeinzen-DerrJKHendricksBLPatilYJImproving access and timeliness of care for veterans with head and neck squamous cell carcinoma: a multidisciplinary team’s approachLaryngoscope2016126362763126267427
   PubMed Web of Science ®Google Scholar
• LicitraLKeilholzUTaharaMEvaluation of the benefit and use of multidisciplinary teams in the treatment of head and neck cancerOral Oncol201659737927424185
   PubMed Web of Science ®Google Scholar
• WuthrickEJZhangQMachtayMInstitutional clinical trial accrual volume and survival of patients with head and neck cancerJ Clin Oncol201533215616425488965
   PubMed Web of Science ®Google Scholar
• SteinerWExperience in endoscopic laser surgery of malignant tumors of the upper aerodigestive tractAdv Otorhinolaryngol1988391351442455969
   PubMedGoogle Scholar
• YeeSTransoral robotic surgeryAORN J20171051738428034402
   PubMed Web of Science ®Google Scholar
• BironVLO’ConnellDABarberBTransoral robotic surgery with radial forearm free flap reconstruction: case control analysisJ Otolaryngol Head Neck Surg20174612028292318
   PubMed Web of Science ®Google Scholar
• CorvòREvidence-based radiation oncology in head and neck squamous cell carcinomaRadiother Oncol200785115617017482300
   PubMed Web of Science ®Google Scholar
• NuttingCMMordenJPHarringtonKJPARSPORT trial management groupParotid-sparing intensity modulated vs conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trialLancet Oncol201112212713621236730
   PubMed Web of Science ®Google Scholar
• KotzTCostelloRLiYPosnerMRSwallowing dysfunction after chemoradiation for advanced squamous cell carcinoma of the head and neckHead Neck200426436537215054740
   PubMed Web of Science ®Google Scholar
• FengFYKimHMLydenTHIntensity-modulated chemoradiotherapy aiming to reduce dysphagia in patients with oropharyngeal cancer: clinical and functional resultsJ Clin Oncol201028162732273820421546
   PubMed Web of Science ®Google Scholar
• EisbruchAKimHMFengFYChemo-IMRT of oropharyngeal cancer aiming to reduce dysphagia: Swallowing organs late complication probabilities and dosimetric correlatesInt J Radiat Oncol Biol Phys2011813e93e9921592678
   PubMed Web of Science ®Google Scholar
• KraaijengaSCOskamIMvan der MolenLHamming-VriezeOHilgersFJMvan den BrekelMWEvaluation of long term (10-years +) dysphagia and trismus in patients treated with concurrent chemo-radiotherapy for advanced head and neck cancerOral Oncol201551878779426027851
   PubMed Web of Science ®Google Scholar
• ChenAMYuYDalyMEFarwellDGBenedictSHPurdyJALong-term experience with reduced planning target volume margins and intensity-modulated radiotherapy with daily image-guidance for head and neck cancerHead Neck201436121766177224174221
   PubMed Web of Science ®Google Scholar
• SchwartzDLGardenASShahSJAdaptive radiotherapy for head and neck cancer--dosimetric results from a prospective clinical trialRadiother Oncol20131061808423369744
   PubMed Web of Science ®Google Scholar
• ChenAMDalyMECuiJMathaiMBenedictSPurdyJAClinical outcomes among patients with head and neck cancer treated by intensity-modulated radiotherapy with and without adaptive replanningHead Neck201436111541154623996502
   PubMed Web of Science ®Google Scholar
• YangHHuWWangWChenPDingWLuoWReplanning during intensity modulated radiation therapy improved quality of life in patients with nasopharyngeal carcinomaInt J Radiat Oncol Biol Phys2013851e47e5423122981
   PubMed Web of Science ®Google Scholar
• BourhisJLapeyreMTortochauxJPhase III randomized trial of very accelerated radiation therapy compared with conventional radiation therapy in squamous cell head and neck cancer: a GORTEC trialJ Clin Oncol200624182873287816782926
   PubMed Web of Science ®Google Scholar
• BlanchardP6th ICHNO: International Conference on Innovative Approaches in Head & Neck Oncology16th–18th March 2017Barcellona, Spain
   Google Scholar
• OrlandiEPalazziMPignoliEFallaiCGiostraAOlmiPRadiobiological basis and clinical results of the simultaneous integrated boost (SIB) in intensity modulated radiotherapy (IMRT) for head and neck cancer: a reviewCrit Rev Oncol Hematol201073211112519409808
   PubMed Web of Science ®Google Scholar
• GutiontovSIShinEJLokBLeeNYCabanillasRIntensity-modulated radiotherapy for head and neck surgeonsHead Neck201638Suppl 1E2368E237326705685
   PubMed Web of Science ®Google Scholar
• OsbornJIs VMAT beneficial for patients undergoing radiotherapy to the head and neck?Radiography (Lond)2017231737628290344
   PubMedGoogle Scholar
• YehDHTamSFungKMacNeilSDTransoral robotic surgery vs radiotherapy for management of oropharyngeal squamous cell carcinoma – A systematic review of the literatureEur J Surg Oncol201541121603161426461255
   PubMed Web of Science ®Google Scholar
• VeresezanOTroussierILacoutAAdaptive radiation therapy in head and neck cancer for clinical practice: state of the art and practical challengesJpn J Radiol2017352435227909957
   PubMed Web of Science ®Google Scholar
• TupchongLScottCBBlitzerPHRandomized study of preoperative vs postoperative radiation therapy in advanced head and neck carcinoma: long-term follow-up of RTOG study 73–03Int J Radiat Oncol Biol Phys199120121281993628
   PubMed Web of Science ®Google Scholar
• CooperJSPajakTFForastiereAARadiation Therapy Oncology Group 9501/IntergroupPostoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neckN Engl J Med2004350191937194415128893
   PubMed Web of Science ®Google Scholar
• BernierJDomengeCOzsahinMEuropean Organization for Research and Treatment of Cancer Trial 22931Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancerN Engl J Med2004350191945195215128894
   PubMed Web of Science ®Google Scholar
• BernierJCooperJSPajakTFDefining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22,931) and RTOG (# 9501)Head Neck2005271084385016161069
   PubMed Web of Science ®Google Scholar
• LangendijkJASlotmanBJvan der WaalIDoornaertPBerkofJLeemansCRRisk-group definition by recursive partitioning analysis of patients with squamous cell head and neck carcinoma treated with surgery and postoperative radiotherapyCancer200510471408141716130134
   PubMed Web of Science ®Google Scholar
• PignonJPle MaîtreAMaillardEBourhisJMACH-NC Collaborative GroupMeta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17346 patientsRadiother Oncol200992141419446902
   PubMed Web of Science ®Google Scholar
• SalamaJKMellLKSchomasDAConcurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experienceJ Clin Oncol200725294581458617925552
   PubMed Web of Science ®Google Scholar
• Cossu RoccaMMaffiniFChioccaSInduction chemotherapy followed by transoral laser microsurgery: a multimodal approach to improve outcomes for locally advanced laryngeal cancer patients?J Clin Oncol201533Suppl 15 abstr e17039
   Web of Science ®Google Scholar
• PopovtzerABurnsteinHStemmerSPhase II organ-preservation trial: Concurrent cisplatin and radiotherapy for advanced laryngeal cancer after response to docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapyHead Neck201739222723327556178
   PubMed Web of Science ®Google Scholar
• DiviVHarrisJHarariPMEstablishing quality indicators for neck dissection: Correlating the number of lymph nodes with oncologic outcomes (NRG Oncology RTOG 9501 and RTOG 0234)Cancer Epub2016715
   Web of Science ®Google Scholar
• ZschaeckSLöckSLegerSFDG uptake in normal tissues assessed by PET during treatment has prognostic value for treatment results in head and neck squamous cell carcinomas undergoing radiochemotherapyRadiother Oncol2017122343744428222892
   PubMed Web of Science ®Google Scholar
• MandalRŞenbabaoğluYDesrichardAThe head and neck cancer immune landscape and its immunotherapeutic implicationsJCI Insight2016117e8982927777979
   PubMed Web of Science ®Google Scholar
• VermorkenJBMesiaRRiveraFPlatinum-based chemotherapy plus cetuximab in head and neck cancerN Engl J Med2008359111116112718784101
   PubMed Web of Science ®Google Scholar
• SpecenierPVermorkenJAfatinib in squamous cell carcinoma of the head and neckExpert Opin Pharmacother20161791295130127160335
   PubMed Web of Science ®Google Scholar
• MachielsJPHaddadRIFayetteJLUX-H&N 1 investigatorsAfatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trialLancet Oncol201516558359425892145
   PubMed Web of Science ®Google Scholar
• DenaroNRussiEGAdamoVColantonioIMerlanoMCPostoperative therapy in head and neck cancer: state of the art, risk subset, prognosis and unsolved questionsOncology2011811212921912194
   PubMed Web of Science ®Google Scholar
• MellmanICoukosGDranoffGCancer immunotherapy comes of ageNature2011480737848048922193102
   PubMed Web of Science ®Google Scholar
• EconomopoulouPPerisanidisCGiotakisEIPsyrriAThe emerging role of immunotherapy in head and neck squamous cell carcinoma (HNSCC): anti-tumor immunity and clinical applicationsAnn Transl Med20164917327275486
   PubMed Web of Science ®Google Scholar
• PaiSIZandbergDPStromeSEThe role of antagonists of the PD-1: PD-L1/PD-L2 axis in head and neck cancer treatmentOral Oncol20166115215827503244
   PubMed Web of Science ®Google Scholar
• BalermpasPRodelFRodelCCD8+ tumor-infiltrating lymphocytes in relation to HPV status and clinical outcome in patients with head and neck cancer after postoperative chemoradiotherapy: a multicentre study of the German cancer consortium radiation oncology group (DKTK-ROG)Int J Cancer2016138117118126178914
   PubMed Web of Science ®Google Scholar
• FerrisRLWhitesideTLFerroneSImmune escape associated with functional defects in antigen-processing machinery in head and neck cancerClin Cancer Res200612133890389516818683
   PubMed Web of Science ®Google Scholar
• FerrisRLImmunology and immunotherapy of head and neck cancerJ Clin Oncol201533293293330426351330
   PubMed Web of Science ®Google Scholar
• ChakravarthyAHendersonSThirdboroughSMHuman papillomavirus drives tumor development throughout the head and neck: improved prognosis is associated with an immune response largely restricted to the oropharynxJ Clin Oncol201634344132414127863190
   PubMed Web of Science ®Google Scholar
• Padilla-QuirarteHOTrejo-MorenoCFierros-ZarateGInterferontau has antiproliferative effects, represses the expression of E6 and E7 oncogenes, induces apoptosis in cell lines transformed with HPV16 and inhibits tumor growth in vivoJ Cancer20167152231224027994659
   PubMed Web of Science ®Google Scholar
• CampoMSGrahamSVCorteseMSHPV-16 E5 down-regulates expression of surface HLA class I and reduces recognition by CD8 T cellsVirology2010407113714220813390
   PubMed Web of Science ®Google Scholar
• HeusinkveldMGoedemansRBrietRJSystemic and local human papillomavirus 16-specific T-cell immunity in patients with head and neck cancerInt J Cancer20121312E74E8522020783
   PubMed Web of Science ®Google Scholar
• LiWDengXMWangCXDown-regulation of HLA class I antigen in human papillomavirus type 16 E7 expressing HaCaT cells: correlate with TAP-1 expressionInt J Gynecol Cancer201020222723220134267
   PubMed Web of Science ®Google Scholar
• UmSJLeeSYKimEJMyoungJNamkoongSEParkJSDown-regulation of human papillomavirus E6/E7 oncogene by arsenic trioxide in cervical carcinoma cellsCancer Lett20021811112212430174
   PubMed Web of Science ®Google Scholar
• StanleyMHPV-immune response to infection and vaccinationInfect Agent Cancer201051920961432
   PubMedGoogle Scholar
• ChenDSMellmanIOncology meets immunology: the cancer-immunity cycleImmunity201339111023890059
   PubMed Web of Science ®Google Scholar
• SeiwertTYBurtnessBMehraRSafety and clinical activity of pembrolizumab for treatment of recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-012): an open-label, multicentre, phase 1b trialLancet Oncol201617795696527247226
   PubMed Web of Science ®Google Scholar
• FerrisRLBlumenscheinGJrFayetteJNivolumab for recurrent squamous-cell carcinoma of the head and neckN Engl J Med2016375191856186727718784
   PubMed Web of Science ®Google Scholar
• SegalNHA phase I dose escalation and cohort expansion study of lirilumab (anti-KIR; BMS-986015) in combination with nivolumab (anti-PD-1; BMS-936558, ONO-4538) in advanced solid tumorsMeeting Library “Abstracts” 2014 ASCO Annual MeetingChicago30 May - 3 June
   Google Scholar
• BaumlJSeiwertTYPfisterDGPembrolizumab for Platinum- and Cetuximab-Refractory Head and Neck Cancer: Results From a Single-Arm, Phase II StudyJ Clin Oncol201735141542154928328302
   PubMed Web of Science ®Google Scholar
• BaxiSSDunnLABurtnessBAAmidst the excitement: a cautionary tale of immunotherapy, pseudoprogression and head and neck squamous cell carcinomaOral Oncol20166214714827776933
   PubMed Web of Science ®Google Scholar
• DenaroNRussiEGMerlanoMCStrategies for non-resectable head and neck cancerCurr Treat Options Oncol201314449250424065559
   PubMed Web of Science ®Google Scholar